Trial Profile
Post marketing surveillance on safety and efficacy of Diquas eye drops 3% in Korean patients in accordance with 'Regulation for re-examination of new drugs, etc."
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2018
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 15 Nov 2018 New trial record